Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

81.90
-0.6800-0.82%
Post-market: 81.900.00000.00%19:59 EDT
Volume:4.58M
Turnover:382.55M
Market Cap:14.87B
PE:-57.13
High:86.25
Open:83.00
Low:81.68
Close:82.58
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:0.61
T/O Rate:3.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:33.42
PE(LYR):-58.09

Loading ...

Movement Alert|Tempus AI Rises 5.15% in Regular Trading, Market Positions for Earnings Recovery Ahead of Q2 Report

Market Focus
·
Jul 31

Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties

Stock Track
·
Jul 31

tempus AI Inc Class A options imply 6.9% move in share price post-earnings

TIPRANKS
·
Jul 31

Median Technologies Partners with Canon’s Olea Medical to Commercialize Eyonis LCS Lung Cancer Screening Software

Reuters
·
Jul 30

Sløk Flags Systemic Cross-Asset Risks; AI Turmoil Is Just The Starting Point

Analyst Calls
·
Jul 30

Form 144 | Tempus AI, Inc. officer and director Eric Lefkofsky proposes to sell 250,000 shares with an aggregate market value of about $10,727,500

Filings Track
·
Jul 30

More Cracks Appear Inside The AI Bond Market!

AI Industry Frontlines
·
Jul 28

Anthropic Considers Mandatory Stock Trading Plan For All Employees Ahead Of IPO, Breaking Industry Norms

Hong Kong & US IPO Tracker
·
Jul 27

AI Sector Under Massive Valuation Reset: Market Abandons Blind Capex Hype, Focuses On Cash Flow & ROI

Bellwether Stocks Movement
·
Jul 27

Movement Alert|Tempus AI Falls 5.26% in Regular Trading, Sector Weakness and Acquisition Uncertainty Weigh Ahead of Earnings

Market Focus
·
Jul 24

Earning Preview: Tempus AI this quarter’s revenue is expected to increase by 27.92%, and institutional views are bullish

Earnings Agent
·
Jul 24

SAP CFO: Generic Chatbots Bring Little Profit; Enterprise Process AI Is True Growth Driver

Analyst Calls
·
Jul 24

Movement Alert|Tempus AI Rises 6.43% in Pre-Market Trading, Stock Recovers as Analyst Endorses Personalis Acquisition Valuation

Market Focus
·
Jul 23

Movement Alert|Tempus AI Rises 5.54% Overnight, Recovering From Post-Acquisition Dip as Analyst Validates Deal Valuation

Market Focus
·
Jul 23

Tempus AI announces national launch of OneOme pharmacogenomics testing

TIPRANKS
·
Jul 22

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Immunome (IMNM) and Incyte (INCY)

TIPRANKS
·
Jul 22

Analysts Are Neutral on These Healthcare Stocks: Cencora (COR), Avita Medical (RCEL)

TIPRANKS
·
Jul 22

Tempus AI (TEM) Stock May Trade Below Fair Value Despite Mixed Checks

Simply Wall St.
·
Jul 22

Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained

TIPRANKS
·
Jul 22

Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring

Benzinga_recent_news
·
Jul 22